Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium Δcya Δcrp: Persistence, stability and immune response in swine

Veterinary Microbiology

Volumn 48, Issue 1-2, 1996, Pages 87-100

  Smerdou, Cristian ^a   Urniza, Alicia ^b   Curtis III, Roy ^c   Enjuanes, Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Laboratorios Sobrino   (Spain)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Coronavirus; Mucosal immunity; Salmonella typhimurium; Swine; TGEV; Transmissible gastroenteritis virus

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; GASTROENTERITIS; GENE EXPRESSION; HUMORAL IMMUNITY; MOLECULAR CLONING; NONHUMAN; SALMONELLA TYPHIMURIUM; SWINE;

ANIMALIA; CORONAVIRUS; GENETTA; SALMONELLA TYPHIMURIUM; SUS SCROFA; TRANSMISSIBLE GASTROENTERITIS VIRUS; TYPHIMURIUM;

EID: 0030069055     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-1135(95)00141-7     Document Type: Article

References (45)

1. Bacon, G.A., Burrows, T.W. and Yates, M., 1950. The effects of biochemical mutation on the virulence of Bacterium typhosum: The virulence of mutants. Brit. J. Exp. Pathol., 32: 714-724.
2. Bacon, G.A., Burrows, T.W. and Yates, M., 1951. The effects of biochemical mutation on the virulence of Bacterium typhosum: The loss of virulence of certain mutants. Brit. J. Exp. Pathol., 32: 85-86.
3. Bennell, M.A. and Watson, D.L., 1980. The interactions of porcine and ovine, serum and colostral immunoglobulins with Staphylococcal protein A. Microbiol. Immunol., 24: 871-878.
4. Birnboim, H.C. and Doly, J., 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research, 7: 1513-1517.
5. Correa, I., Gebauer, F., Bullido, M.J., Suñé, C., Baay, M.F.D., Zwaagstra, K.A., Posthumus, W.P.A., Lenstra, J.A. and Enjuanes, L., 1990. Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. J. Gen. Virol., 71: 271-279.
6. Correa, I., Jiménez, G., Suñé, C., Bullido, M.J. and Enjuanes, L., 1988. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus. Res., 10: 77-94.
7. Curtiss III, R., 1965. Chromosomal aberrations associated with mutation to bacteriophage resistance in Escherichia coli. J. Bacteriol., 89: 28-40.
8. Curtiss III, R., 1990. Attenuated Salmonella strains as live vectors for the expression of foreign antigens. In: G.C. Woodrowand M.M. Levine, (Eds.), New generation vaccines. Marcel Dekker, Inc., New York, 161-188.
9. Curtiss III, R., Charamella, L.J., Stallions, D.R. and Mays, J.A., 1968. Parental functions during conjugation in Escherichia coli K-12. Bacteriol. Rev., 32: 320-348.
10. Curtiss III, R., Galan, J.E., Nakayama, K. and Kelly, S.M., 1990. Stabilization of recombinant avirulent vaccine strains in vivo. Res. Microbiol., 141: 797-805.
11. Curtiss III, R. and Kelly, S.M., 1987. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun., 55: 3035-3043.
12. de Groot, R.J., Luytjes, W., Horzineck, M.C., van der Zeijst, B.A.M., Spaan, W.J.M. and Lenstra, J.A., 1987. Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J. Mol. Biol., 196: 963-966.
13. Delmas, B., Gelfi, J. and Laude, H., 1986. Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein. J. Gen. Virol., 67: 1405-1418.
14. Delmas, B., Rasschaert, D., Godet, M., Gelfi, J. and Laude, H., 1990. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike protein. J. Gen. Virol., 71: 1313-1323.
15. Doggett, T.A., Jagusztyn-Krynicka, E.K. and Curtiss III, R., 1993. Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium. Infect. Immun., 61: 1859-1866.
16. Enjuanes, L. and Van der Zeijst, B.A.M., 1995. Molecular basis of transmissible gastroenteritis coronavirus (TGEV) epidemiology. In: S.G. Siddell (Eds.), The Coronaviridae, Plenum Press, New York. 337-376.
17. Galan, J.E., Nakayama, K. and Curtiss, R., 1990. Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene, 94: 29-35.
18. Garwes, D.J., Lucas, M.H., Higgins, D.A., Pike, B.V. and Cartwright, S.F., 1978. Antigenicity of structural components from porcine transmissible gastroenteritis virus. Vet. Microbiol., 3: 179-190.
19. Gebauer, F., Posthumus, W.A.P., Correa, I., Suñé, C., Sánchez, C.M., Smerdou, C., Lenstra, J.A., Meloen, R. and Enjuanes, L., 1991. Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus. Virology, 183: 225-238.
20. Germanier, R. and Furer, E., 1971. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of galE mutants of Salmonella typhimurium. Infect. Immun., 4: 663-673.
21. Godet, M., L'Haridon, R., Vautherot, J.F. and Laude, H., 1992. TGEV coronavirus ORF4 encodes a membrane protein that is incorporated into virions. Virol., 188: 666-675.
22. Hoiseth, S.K. and Stocker, B.A.D., 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature, 291: 238-239.
23. Jiménez, G., Correa, I., Melgosa, M.P., Bullido, M.J. and Enjuanes, L., 1986. Critical epitopes in transmissible gastroenteritis virus neutralization. J. Virol., 60: 131-139.
24. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
25. Montgomery, P.C., Cohn, J. and Lally, E.T., 1974. The induction and characterization of secretory antibodies. Adv. Exp. Med., Biol., 45: 453.
26. + expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Biotechnology, 6: 693-697.
27. Posthumus, W.P.A., Lenstra, J.A., Schaaper, W.M.M., van Nieuwstadt, A.P., Enjuanes, L. and Meloen, R.H., 1990a. Analysis and simulation of a neutralizing epitope of transmissible gastroenteritis virus. J. Virol., 64: 3304-3309.
28. Posthumus, W.P.A., Meloen, R.H., Enjuanes, L., Correa, I., van Nieuwestadt, A. and Koch, G., 1990b. Linear neutralizing epitopes on the peplomer protein of coronaviruses. Adv. Exp. Med. Biol., 276: 181-188.
29. Rasschaert, D. and Laude, L., 1987. The predicted primary structure of the peplomer protein E2 of the porcine coronavirus transmissible gastroenteritis virus. J. Gen. Virol., 68: 1883-1890.
30. Saif, L.J. and Wesley, R.D., 1992. Transmissible Gastroenteritis. In: A.D. Lemanet al., (Eds.), Diseases of Swine. Wolfe Publishing Ltd, 362-386.
31. Sambrook, J., Fritsch, E.F. and Maniatis, T., 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
32. Sáncher, C.M., Gebauer, F., Suñé, C., Méndez, A., Dopazo, J. and Enjuanes, L., 1992. Genetic evolution and tropism of transmissible gastroenteritis coronaviruses. Virology, 190: 92-105.
33. Sánchez, C.M., Jiménez, G., Laviada, M.D., Correa, I., Suñé, C., Bullido, M.J., Gebauer, F., Smerdou, C., Callebaut, P., Escribano, J.M. and Enjuanes, L., 1990. Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology, 174: 410-417.
34. Sanz, A., García-Barreno, B., Nogal, M.L., Viñuela, E. and Enjuanes, L., 1985. Monoclonal antibodies specific for African swine fever virus proteins. J. Virol., 54: 199-206.
35. Schödel, F., Peterson, D., Hughes, J. and Milich, D., 1993. Avirulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination. Vaccine, 11: 143.
36. Siddell, S., Wege, H. and Volker, M., 1983. The biology of coronaviruses. J. Gen. Virol, 64: 761-776.
37. Spaan, W., Cavanagh, D. and Horzinek, M.C., 1988. Coronaviruses: structure and genome expression. J. Gen. Virol., 69: 2939-2952.
38. Spaan, W., Cavanagh, D. and Horzinek, M.C., 1990. Coronaviruses. In: M.H.V. van Regenmorteland and A.R. Neurath (Eds.), Immunochemistry of Viruses II. The Basis for Serodiagnosis and Vaccines. Elsevier, 359-379.
39. Stabel, T.J., Mayfield, J.E., Tabatabai, L.B. and Wannemuehler, M.J., 1990. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect. Immun., 58: 2048-2055.
40. Stabel, T.J., Mayfield, J.E., Tabatabai, L.B. and Wannemuehler, M.J., 1991. Swine immunity to an attenuated Salmonella typhimurium mutant containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus. Infect. Inmmun., 59: 2941-2947.
41. Stone, S.S., Kemeny, L.J., Woods, R.D. and Jensen, M.T., 1977. Efficacy of isolated colostral IgA, IgG, and IgM(A) to protect neonatal pigs against the coronavirus transmissible gastroenteritis. Am. J. Vet. Res., 38: 1285-1288.
42. Sturman, L.S. and Holmes, K.V., 1983. The molecular biology of coronaviruses. Adv. Viral Res., 28: 35-112.
43. Wesley, R.D., Woods, R.D., Correa, I. and Enjuanes, L., 1988. Lack of protection in vivo with neutralizing monoclonal antibodies to transmissible gastroenteritis virus. Vet. Microbiol., 18: 197.
44. Yanisch-Perron, P., Vieria, J. and Messing, J., 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene, 33: 103-119.
45. Zinder, N., 1958. Lysogenization and superinfection immunity in Salmonella. Virology, 5: 291-326.